- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
Abemaciclib, as a CDK4/6 inhibitor, requires attention to blood toxicity, liver and kidney function monitoring, embryo fetal toxicity, and drug...
As a CDK4/6 inhibitor, Abemaciclib is mainly used in the treatment of HR+/HER2 breast cancer. Its side effects involve the blood system, digest...
As an endothelin receptor antagonist, Macitentan's precautions mainly involve embryotoxicity, liver function monitoring and blood system effect...
Macitentan, as an endothelin receptor antagonist, is mainly used for the treatment of pulmonary arterial hypertension. Its side effects involve...
Idelalisib, as a PI3K δ inhibitor, should be monitored for liver toxicity, infection risk, and medication management in special populations. It...
Idelalisib, as a PI3K δ inhibitor, has side effects mainly including hepatotoxicity, severe infections, and gastrointestinal reactions, which n...
Iqirvo, as a medication for treating specific liver diseases, requires attention to liver function monitoring, drug interactions, and medicatio...
Iqirvo, as a PPAR agonist drug, commonly has side effects including liver dysfunction, gastrointestinal reactions, and increased risk of infect...
Abrotinib is an oral JAK1 inhibitor primarily used for the treatment of moderate to severe atopic dermatitis. Long term use requires an evaluat...
Attention should be paid to infection risk monitoring, specific population contraindications, and drug interaction management when using Abroti...
